GDNF/RET signaling in dopamine neurons in vivo

  • James A. Conway
  • , Selvi Ince
  • , Stephanie Black
  • , Edgar R. Kramer*
  • *Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Abstract

The glial cell line–derived neurotrophic factor (GDNF) and its canonical receptor Ret can signal both in tandem and separately to exert many vital functions in the midbrain dopamine system. It is known that Ret has effects on maintenance, physiology, protection and regeneration in the midbrain dopamine system, with the physiological functions of GDNF still somewhat unclear. Notwithstanding, Ret ligands, such as GDNF, are considered as promising candidates for neuroprotection and/or regeneration in Parkinson’s disease, although data from clinical trials are so far inconclusive. In this review, we discuss the current knowledge of GDNF/Ret signaling in the dopamine system in vivo as well as crosstalk with pathology-associated proteins and their signaling in mammals.

Original languageEnglish
Pages (from-to)135-146
Number of pages12
JournalCell and Tissue Research
Volume382
Issue number1
DOIs
Publication statusPublished - 1 Oct 2020

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Histology
  • Cell Biology

Keywords

  • Cell survival
  • GDNF
  • Midbrain dopamine system
  • Protection
  • Regeneration
  • Ret

Fingerprint

Dive into the research topics of 'GDNF/RET signaling in dopamine neurons in vivo'. Together they form a unique fingerprint.

Cite this